|
(Health-NewsWire.Net, July 29, 2015 ) Myasthenia gravis is an autoimmune disease that affects the nerves and muscles and is characterized by muscle weakness and fatigue, especially weakness of the muscles controlling eye and eyelid movement, facial expression, chewing and talking. In some cases the muscles controlling breathing are also affected, which can lead to respiratory failure that requires intubation and mechanical ventilation, known as a myasthenic crisis. The muscle weakness seen in myasthenia gravis is most often caused by circulating antibodies that mistakenly attack healthy tissue and inhibit normal neuromuscular transmission by blocking or damaging muscle receptor cells.
Request a sample copy of this report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=394093 . (This is a premium report price at US$3995 for a single user PDF license)
GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of myasthenia gravis in the 7MM, from 106,845 cases in 2014 to 119,939 cases in 2024, at an Annual Growth Rate (AGR) of 1.23% in the forecast period. The highest number of diagnosed prevalent cases of myasthenia gravis fell into the =75 year age group in the 7MM. The majority of diagnosed prevalent cases of myasthenia gravis in the 7MM in 2014 were women. The US and the 5EU markets follow a similar pattern, in which Class III has the highest number of diagnosed prevalent cases. Japan, however, has more cases in Class II than any other Class.
Download the PDF of this report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=394093 . (This is a premium report price at US$3995 for a single user PDF license)
To build the epidemiological forecast of myasthenia gravis in the 7MM, GlobalData epidemiologists reviewed the literature and obtained country-specific, population-based studies that reported myasthenia gravis prevalence as determined via medical record reviews. GlobalData epidemiologists obtained country-specific diagnosed prevalence data for the US, Italy, the UK, and Japan, thereby providing valuable analysis of epidemiological trends amongst the 7MM. This forecast also includes age- and sex-specific segmentations, thereby providing detailed information about the characteristic of the disease in each market.
Scope:
• The Myasthenia Gravis EpiCast Report provides an overview of the risk factors and global trends of myasthenia gravis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of myasthenia gravis, segmented by sex, age, and Myasthenia Gravis Foundation of America (MGFA) classifications (Class I, Class II, Class III, Class IV, and Class V).
• The myasthenia gravis epidemiology report is written and developed by Mastersand PhD-level epidemiologists.
• The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=394093 . (This is a premium report price at US$3995 for a single user PDF license)
Reasons to Buy:
• Develop business strategies by understanding the trends shaping and driving the global myasthenia gravis market.
• Quantify patient populations in the global myasthenia gravis market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for myasthenia gravis therapeutics in each of the markets covered.
• Identify the percentage of myasthenia gravis prevalent cases by class.
More reports on therapeutics Market are available at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .
There has been a great revolution that has been experienced in the field of medical science to make healthy living possible. The contribution of the so much research in the field of therapeutics is noteworthy in this regard. By definition, therapeutics is the field of medical science that deals with the various therapies that can help to cure the disease and pain. In fact, there are different therapies that exist and can provide the treatment in a non-surgical manner. Fighting with the worst of the diseases is only possible with the help of the so much innovation in the field of therapeutics.
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
